NEW YORK, Sept. 22, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) from June 17, 2015 through August 10, 2017, both dates inclusive (the “Class Period”) of the important October 24, 2017 lead plaintiff deadline in the first filed class action commenced by the firm. The lawsuit seeks to recover damages for Dr. Reddy’s investors under the federal securities laws.
To join the Dr. Reddy’s class action, go to http://www.rosenlegal.com/cases-1191.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Dr. Reddy’s lacked an effective corporate quality system; and (2) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 24, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1191.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 



